What Will Big Pharma Try to Sell Us Next—the Brooklyn Bridge?

Administrator 0 ANH-USA
Print Email

The Food and Drug Administration recently approved a new class of cholesterol-lowering drugs that will cost more than $14,000 a year. Why did a new class of super-expensive statins need to be developed? Partly because the older statins are coming off patent and cannot be sold at high prices anymore. Also because of the wide [...]
Read Full Article


You can contact us at: